For decades, the pharmaceutical industry has been locked in an expensive, time-consuming cycle of iterative development. Formulation...
Pevita Pearce
For nearly a decade, the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard...
By Nathan Owens | July 31, 2026 In a landmark move for the domestic biopharmaceutical supply chain,...
Executive Summary: A Milestone for Global Health On December 20, 2024, the landscape of international public health...
The field of genomics—the study of the entirety of an organism’s genetic makeup—is often portrayed through the...
By [Your Name/Journalistic Desk] Published in recognition of Genetic Counsellor Awareness Day 2024 As the medical landscape...
A cancer diagnosis for a parent can be a deeply unsettling experience for an entire family, and...
Introduction: The Unforeseen Ripple Effect of Cancer A cancer diagnosis is a life-altering event, casting a long...
In a unified and urgent call to action, the President of Brazil, Luiz Inácio Lula da Silva,...
In a significant move that underscores the pharmaceutical industry’s shifting focus, Johnson & Johnson (J&J) has secured...
